Clinical Trial: A Study of Imvotamab in Severe Systemic Lupus Erythematosus
Study Status: Completed
Recruit Status: RECRUITING
Condition: Systemic Lupus Erythematosus
Study Type: INTERVENTIONAL
Official Title: A Phase 1b, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Imvotamab in Participants With Severe Systemic Lupus Erythematosus Who Have Fa
Brief Summary:
The purpose of this study is to determine the safety and tolerability of imvotamab in patients with severe systemic lupus erythematosus who have failed prior therapies.Participants will be given imvotamab through a vein (i.e., intravenously).
Read more